Alemken Eyayu Abuhay

Mr. Alemken Eyayu Abuhay


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
BMBerihun Agegn Mengistie
Berihun Agegn Mengistie
GAGetie Mihret Aragaw
Getie Mihret Aragaw
TATazeb Alemu Anteneh
Tazeb Alemu Anteneh
KWKindu Yinges Wondie
Kindu Yinges Wondie
AKAlemneh Tadesse Kassie
Alemneh Tadesse Kassie
NTNuhamin Tesfa Tsega
Nuhamin Tesfa Tsega
Background: Precancerous cervical lesions, or cervical intraepithelial neoplasia (CIN), represent a significant precursor to cervical cancer, posing a considerable threat to women’s health globally, particularly in developing countries. In Africa, the burden of premalignant cervical lesions is not well studied. Therefore, the main purpose of this systematic review and meta-analysis was to determine the overall prevalence of precancerous cervical lesions and identifying determinants among women who underwent cervical cancer screening in Africa. Methods: This study followed the Preferred Reporting Item Review and Meta-analysis (PRISMA) guidelines. The protocol for this systematic review and meta-analysis was registered on the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD42025645427). We carried out a systematic and comprehensive search on electronic databases such as PubMed and Hinari. In addition, Google Scholar and ScienceDirect were utilized to find relevant studies related to precancerous cervical lesions. Data from the included studies were extracted using an Excel spreadsheet and analyzed using STATA version 17. The methodological quality of the eligible studies was examined using the Joanna Briggs Institute (JBI) assessment tool. Publication bias was checked by using the funnel plot and Egger’s tests. A random-effects model using the Der Simonian Laird method was used to estimate the pooled prevalence of pre-cancerous cervical lesions in Africa. The I-squared and Cochrane Q statistics were used to assess the level of statistical heterogeneity among the included studies. Results: A total of 112 eligible articles conducted in Africa, encompassing 212,984 study participants, were included in the quantitative meta-analysis. Thus, the pooled prevalence of pre-cancerous cervical lesions in Africa was 17.06% (95% confidence interval: 15.47%−18.68%). In this review, having no formal education (AOR = 4.07, 95% CI: 1.74, 9.53), being rural dweller(AOR = 2.38, 95% CI: 1.64, 3.46), history of STIs (AOR = 3.94, 95% CI: 2.97, 5.23), history of having multiple partners (AOR = 2.73, 95% CI: 2.28, 3.28), early initiation of coitus (AOR = 2.77, 95% CI: 2.11, 3.62), being HIV-seropositive women (AOR = 3.33, 95% CI: 2.32, 4.78), a CD4 count <200 cells/mm³ (AOR = 5.17, 95% CI: 1.70, 15.71), not being on ART (AOR = 2.58, 95% CI: 1.45, 4.58), smoking (AOR = 3.91, 95% CI: 1.43, 10.67) and prolonged use of oral contraceptive pills (AOR = 4.39, 95% CI: 2.77, 6.96) were significantly associated with precancerous cervical lesions. Conclusions: In Africa, the overall prevalence of pre-cancerous cervical lesions is high (17%). The findings of this review highlight that health professionals, health administrators, and all other concerned bodies need to work in collaboration to expand comprehensive cervical cancer screening methods in healthcare facilities for early detection and treatment of cervical lesions. In addition, increasing community awareness and health education, expanding visual inspection of the cervix with acetic acid in rural areas, offering special attention to high-risk groups (HIV-positive women), encouraging adherence to antiretroviral therapy for HIV-positive women, overcoming risky sexual behaviors and practices, and advocating early detection and treatment of precancerous cervical lesions.

20 February 2026 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
AAAlemken Eyayu Abuhay
Alemken Eyayu Abuhay
MAMengstu Melkamu Assaye
Mengstu Melkamu Assaye
TZTadele Amare Zeleke
Tadele Amare Zeleke
SMSerku Abate Mihret
Serku Abate Mihret
AGAmare Belete Getahun
Amare Belete Getahun
BMBerihun Agegn Mengistie
Berihun Agegn Mengistie
Mpox is an emerging global health threat with increasing frequency and geographic spread recently. Healthcare providers play a pivotal role in outbreak pre

13 April 2026 in PLOS ONE
Verified
Journal Article
Open access
BMBerihun Agegn Mengistie
Berihun Agegn Mengistie
GAGetie Mihret Aragaw
Getie Mihret Aragaw
GMGebrye Gizaw Mulatu
Gebrye Gizaw Mulatu
KWkindu Yinges Wondie
kindu Yinges Wondie
AKAlemneh Tadesse Kassie
Alemneh Tadesse Kassie
NTNuhamin Tesfa Tsega
Nuhamin Tesfa Tsega
Background: The elimination of mother-to-child transmission of human immunodeficiency virus (HIV) is a key global public health priority. In Africa, virologic failure among people living with HIV continues to pose a significant public health challenge, affecting both individual well-being and community health. Maintaining viral load suppression is crucial to prevent vertical transmission of HIV and to minimize maternal morbidity and mortality. To stop the vertical transmission of HIV and lower the risk of maternal morbidity and mortality, it is important to achieve viral load suppression. Although many African countries have adopted the global 95-95-95 targets, comprehensive data on virologic suppression among pregnant and lactating mothers across the continent remains limited. The objective of this systematic review and meta-analysis was to determine the pooled estimate of virologic suppression and to examine the factors associated with it among HIV-positive pregnant and lactating women on antiretroviral therapy in Africa. Methods: This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO; CRD420251186121). We carried out a thorough systematic review by examining PubMed, ScienceDirect, Hinari, and Google Scholar for relevant studies. Data from the studies were retrieved using an Excel sheet and analyzed with STATA version 17. The Joanna Briggs Institute appraisal tool was used to evaluate the methodological quality of studies. A random-effects model with restricted maximum likelihood (REML) was applied to determine the pooled prevalence of virologic suppression (viral load threshold ≤1000 copies/ml) among pregnant and lactating mothers in Africa. A funnel plot and the Egger’s test were used to investigate publication bias. Statistical heterogeneity was assessed using the I 2 statistic and Cochrane’s Q test. Results: A total of 55 eligible studies, comprising 304,883 participants, were included in the quantitative meta-analysis. Accordingly, the overall prevalence of virologic suppression among HIV-positive pregnant and breastfeeding women in Africa was 80.86% (95% CI: 77.63%, 84.09%, I 2 = 99.84%). In contrast, the pooled estimate for achieving an undetectable viral load was substantially lower, at 60.92% (95% CI: 52.46%, 69.39%; I 2 = 99.91%). Virologic suppression was significantly associated with women’s age (15–24 years) (AOR = 0.49; 95% CI: 0.32–0.77), disclosure of HIV status to a partner (AOR = 1.66; 95% CI: 1.31–2.11), first-line antiretroviral therapy regimen (AOR = 6.53; 95% CI: 1.93–22.06), and good antiretroviral drug adherence (AOR = 3.61; 95% CI: 1.18–11.02). In addition, other socio-demographic variables, higher educational level, being married/cohabitant, urban residency, healthcare utilization (time of ANC booking, time of ART initiation, duration of ART), fear of stigma, distance to health facility, shortage of health professionals, ART drug stock-out, and lack of HIV care commodities were significantly associated with virologic suppression among HIV-positive pregnant and lactating women in Africa. Conclusion: The pooled estimate of virologic suppression among HIV-positive pregnant and breastfeeding women in Africa was approximately 81%, below the global target of 95% virological suppression. This emphasizes the necessity of targeted strategies for younger HIV-positive women, disclosing HIV status, initiating first-line antiretroviral regimens, and promoting antiretroviral treatment adherence. Upgrading health care systems to enable regular viral load monitoring, as well as addressing socio-demographic and antiretroviral therapy-related variables, are vital steps towards attaining and sustaining VS in these groups of population, ultimately assisting in achieving elimination of MTCT of HIV.

6 April 2026 in Health and Quality of Life Outcomes
Verified
Journal Article
Open access
PDF file
AAAlemken Eyayu Abuhay
Alemken Eyayu Abuhay
BMBerihun Agegn Mengistie
Berihun Agegn Mengistie
FKFisseha Yetwale Kassie
Fisseha Yetwale Kassie
GAGetnet Azanaw
Getnet Azanaw
TZTadele Amare Zeleke
Tadele Amare Zeleke
MAMengstu Melkamu Asaye
Mengstu Melkamu Asaye
Mothers’ health-related quality of life (HRQoL) is frequently compromised when their neonates are admitted to neonatal intensive care units (NICUs),